New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe....
Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment...
Clinical milestone underscores BD’s growing role in self-administered drug delivery and expands real-world evaluation of its on-body injection platform for large-volume biologics....
The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments....
As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network...
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions ...
